Company profile: Surepharm
1.1 - Company Overview
Company description
- Provider of pharmaceutical contract manufacturing and assembly services for solid dose medicinal and healthcare products, including generic and branded formulations. Offers formulation development; tablet and hard shell capsule manufacturing to GMP; blister packing with child-resistant options; pots/bottles filling; and analytical support, pilot batch management, and stability studies.
Products and services
- Tablet and Hard Shell Capsule Manufacturing: Produces GMP-compliant tablet and hard shell capsule dosage formats for solid dose medicinal products within the pharmaceutical sector
- Pharmaceutical Manufacturing and Assembly: Delivers industrial-scale production and assembly of solid dose medicinal and healthcare products, handling both generic and branded formulations, aiming for the highest levels of product quality
- Formulation Development: Architects custom-engineered formulations tailored to specific product requirements, accommodating a wide range of batch sizes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Surepharm
Peptido
HQ: Germany
Website
- Description: Provider of GMP-compliant synthesis of pharmaceutical active ingredients, delivering services from lab-scale and pilot quantities to industrial-scale production for the pharmaceutical industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peptido company profile →
Minerva Imaging
HQ: Denmark
Website
- Description: Provider of contract research services for translational cancer research and drug development, offering molecular imaging, oncology, radionuclide therapy, and cardiovascular disease services. Responds to customer inquiries via phone, contact form, and email.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minerva Imaging company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
FIS
HQ: Italy
Website
- Description: Provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and intermediates, supporting clients from development to commercial production. Offers generic API development and manufacturing, veterinary CDMO, and specialized sterile manufacturing, micronization, lyophilization, and spray drying. Produces 100+ APIs across anticancer, steroids, psychotropics, and veterinary classes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FIS company profile →
Tetris Pharma
HQ: United Kingdom
Website
- Description: Provider of a pan-European platform to market a range of prescription products, offered by a UK-based speciality pharmaceutical company with extensive experience of launching products in the UK and across Europe, focused on areas of unmet clinical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetris Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Surepharm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Surepharm
2.2 - Growth funds investing in similar companies to Surepharm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Surepharm
4.2 - Public trading comparable groups for Surepharm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →